Mind Medicine MindMed Inc
For the period ended Dec 31, 2023. Filed Feb 28, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 28, 2024
DFTX$35.39+6.4%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Shareholders’ Equity
(in thousands, except share amounts)
| Common Shares | ||||||
|---|---|---|---|---|---|---|
| Shares | Amount | Additional Paid-In Capital | Accumulated OCI | Accumulated Deficit | Total | |
| Balance, December 31, 2021 | 28,126,414 | — | 288,290 | 1,046 | (137,672) | 151,664 |
| Issuance of common shares and warrants, net of share issuance costs | 9,370,476 | — | 42,297 | — | — | 42,297 |
| Exercise of CAD Financing warrants | 76,021 | — | 708 | — | — | 708 |
| Exercise of stock options | 38,275 | — | 206 | — | — | 206 |
| Settlement of restricted share unit awards | 367,950 | — | — | — | — | — |
| Withholding taxes paid on vested restricted share units | — | — | (407) | — | — | (407) |
| Stock-based compensation expense | — | — | 13,664 | — | — | 13,664 |
| Net loss and comprehensive loss | — | — | — | (419) | (56,796) | (57,215) |
| Balance, December 31, 2022 | 37,979,136 | — | 344,758 | 627 | (194,468) | 150,917 |
| Issuance of common shares, net of share issuance costs | 2,232,113 | — | 7,823 | — | — | 7,823 |
| Exercise of 2022 USD Financing Warrants | 27,000 | — | 178 | — | — | 178 |
| Exercise of stock options | 13,333 | — | 49 | — | — | 49 |
| Settlement of restricted share unit awards | 849,721 | — | — | — | — | — |
| Stock-based compensation expense | — | — | 15,183 | — | — | 15,183 |
| Net loss and comprehensive loss | — | — | — | (284) | (95,732) | (96,016) |
| Balance, December 31, 2023 | 41,101,303 | $— | $367,991 | $343 | $(290,200) | $78,134 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.